EIKN
Eikon Therapeutics, Inc. Common Stock • NASDAQ
$11.42 ▲ 5.35% (+0.58)
EIKN
Eikon Therapeutics, Inc. Common StockNASDAQ • $11.42 ▲ 5.35% (+0.58)
Market Cap $31.99 M
52w High $17.40
52w Low $8.58
P/E -1.85
Volume 310.77K
Outstanding Shares 2.95M
Market Cap $31.99 M
52w High $17.40
52w Low $8.58
P/E -1.85
Volume 310.77K
Outstanding Shares 2.95M
About Eikon Therapeutics, Inc. Common Stock
https://eikontx.comEikon Therapeutics, Inc., operates as a clinical biopharmaceutical company in the United States. It develops innovative medicines to address serious unmet medical needs. It develops a platform that permits precise characterization of protein interactions in living cells.
CEO
Roger Perlmutter
Compensation Summary
(Year )
Total Compensation (Unknown At The Moment)
Industry Biotechnology
Sector Healthcare
Went public February 5, 2026
Method of going public IPO
Full time employees 484
MAY
8 FRI
Upcoming Earnings
Date May 8, 2026
Day Friday
Revenue Est. —
ETFs Holding This Stock
Summary
Total 18
Showing Top 3 of 18
Most Recent Analyst Grades
Grade Summary
Underperform 1
Showing Top 1 of 1
Price Target
Target High $0
Target Low $0
Target Median $0
Target Consensus $0